Sequana Medical NV
F:2SE

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
F:2SE
Watchlist
Price: 0.512 EUR Market Closed
Market Cap: €15.6m

Sequana Medical NV
Investor Relations

Sequana Medical makes implantable medical devices that help remove unwanted fluid from the body. Its best-known product is the alfapump, a small pump system that moves excess abdominal fluid out of the body in patients with severe liver disease and related fluid buildup. The company is also developing other treatments for fluid overload, including therapies aimed at heart failure patients. Its customers are mainly hospitals and specialist doctors who treat advanced liver and heart disease. Sequana Medical does not sell to patients directly; instead, its devices are used in clinical care settings and bought through hospital purchasing channels. The company makes money by selling its devices and, where applicable, related services and clinical use support. What makes Sequana Medical different is that it focuses on a very specific problem that medicines often do not solve well: chronic fluid overload. Rather than offering general hospital equipment, it targets a narrow group of patients with serious conditions where doctors need a more direct way to manage excess fluid and improve day-to-day comfort.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ian Crosbie
CEO & Executive Director
No Bio Available
Ms. Kirsten Van Bockstaele
Chief Financial Officer
No Bio Available
Ms. Lies Vanneste
Director of Investor Relations
No Bio Available
Mr. Martijn Blom
Chief Commercial Officer
No Bio Available
Dr. Oliver Godje M.D., Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
OOST-VLAANDEREN
Ghent
Kortrijksesteenweg 1112, Sint-Denijs-Westrem
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett